HQY
HealthEquity, a leading health savings account (HSA) and consumer-directed benefits platform, has announced its fourth-quarter fiscal 2026 earnings results, exceeding expectations with record highs across various key metrics. The company's strong execution, significant margin expansion, and record HSA sales have positioned it for continued growth in the upcoming
SATL
Good morning, and welcome to the Satellogic Q4 and full year 2025 financial results conference call. All lines have been placed on listen-only mode, and the floor will be open for your questions following the presentation. In a remarkable display of strategic growth and financial discipline, Satellogic has emerged as
QFIN
Despite a challenging market environment, Qfin Holdings, a leading credit-tech platform in China's consumer finance industry, demonstrated resilience and stability in its fourth quarter 2025 earnings. As reported on the company's recent conference call transcript, Qfin successfully navigated the systemic restructuring of the industry under regulatory
WSM
The fourth quarter and fiscal year 2025 earnings conference call for Williams-Sonoma, Inc. has provided a glimpse into the company's resilience and growth amidst an uncertain macro environment. President and Chief Executive Officer Laura Alber highlighted the company's ability to deliver sustainable, profitable growth in a
JBL
The second quarter fiscal 2026 earnings conference call for Jabil has come to a close, and the company's performance is nothing short of impressive. With net revenue exceeding expectations at $8.3 billion, Jabil's intelligent infrastructure segment continues to be the primary driver of growth, with
NEPH
Nephros, Inc., the leading provider of advanced water filtration technologies, has announced outstanding results for its fourth quarter and fiscal year 2025. During a conference call on March 12, 2026, Nephros' President and Chief Executive Officer, Robert Banks, shared the company's impressive achievements with investors and analysts.
UEIC
Universal Electronics (UEI) has reported a decisive fourth quarter and year-end 2025 financial results, marked by operational discipline and measurable progress towards profitability. Despite challenging market conditions in the traditional home entertainment business, UEI successfully drove a strategy to diversify its revenue base, with connected home growing 16% year-over-year. The
ICCM
IceCure Medical, a pioneering medical device company, has made significant strides in the field of cryoablation for breast cancer treatment. According to its Q4 2025 conference call transcript, the company has achieved record-breaking revenue and secured market leadership in this emerging technology. The company's CEO, Eyal Shamir, reported
CTMX
CytomX Therapeutics has made significant strides in its Q4 2025 financial results and Varseta Phase I dose expansion data, marking a major milestone in the company's mission to revolutionize cancer treatment. The recent conference call highlighted the impressive progress made by the EpCAM-targeting Probody antibody-drug conjugate Varseta-M in
LIDR
AEye, a leader in high-performance lidar (Light Detection and Ranging) solutions, has reported strong financial results for its fourth quarter and full year 2025. The company's executives, Matt Fisch, Chief Executive Officer, and Conor Tierney, Chief Financial Officer, shared the highlights of the quarter during a recent conference
EVEX
Eve Holding, Inc. has marked its fourth quarter 2025 as one of the most significant periods in the company's history. The aerospace leader concluded the first flight of its engineering prototype last December, after a series of extensive ground tests on all systems were completed. The short yet
HFFG
HF Foods Group, a leading distributor of food products in the United States, has reported a robust performance in its fourth quarter earnings for 2025, despite headwinds faced by the broader food service industry. According to Felix Lin, President and Chief Executive Officer of HF Foods Group, the company drove